AbbVie Inc.
ABBV
$172.99
$1.310.76%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.60% | 3.83% | 4.31% | 0.70% | -5.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.60% | 3.83% | 4.31% | 0.70% | -5.42% |
| Cost of Revenue | 5.14% | -3.62% | -0.14% | 1.11% | 1.14% |
| Gross Profit | 5.79% | 7.23% | 6.24% | 0.50% | -7.89% |
| SG&A Expenses | -19.02% | 22.38% | 5.11% | 2.36% | 14.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -104.14% | -- | -- | -- | 17,000.00% |
| Total Operating Expenses | -2.66% | 9.87% | 6.05% | 3.20% | 8.97% |
| Operating Income | 23.74% | -8.53% | 1.15% | -5.15% | -26.69% |
| Income Before Tax | -287.21% | 6.71% | -17.78% | 269.47% | -59.12% |
| Income Tax Expenses | -678.87% | 202.33% | 32.59% | 63.68% | -21.30% |
| Earnings from Continuing Operations | -102.79% | -12.18% | -32.26% | 469.29% | -66.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 150.00% | 0.00% | 0.00% | -50.00% | -300.00% |
| Net Income | -102.68% | -12.20% | -32.31% | 472.80% | -66.76% |
| EBIT | 23.74% | -8.53% | 1.15% | -5.15% | -26.69% |
| EBITDA | 16.61% | -8.02% | -1.00% | -4.17% | -20.70% |
| EPS Basic | -103.95% | -12.32% | -32.48% | 496.43% | -66.95% |
| Normalized Basic EPS | 20.91% | -10.05% | 0.14% | -4.74% | -26.72% |
| EPS Diluted | -104.09% | -12.32% | -32.48% | 496.43% | -66.95% |
| Normalized Diluted EPS | 20.91% | -9.99% | 0.20% | -4.64% | -26.72% |
| Average Basic Shares Outstanding | -0.17% | 0.11% | 0.06% | -0.06% | -0.34% |
| Average Diluted Shares Outstanding | -0.17% | 0.06% | 0.00% | -0.17% | -0.34% |
| Dividend Per Share | 5.81% | 4.73% | 4.73% | 4.73% | 4.73% |
| Payout Ratio | -40.16% | 0.19% | 0.55% | -0.82% | 2.15% |